Healthcare · National
Experimental GLP-1 drug demonstrates pain relief in people with osteoarthritis during trials
A pooled analysis of the studies found that about two-thirds of participants receiving the drug retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving a placebo
Verified Timeline
No verified timeline updates.
What is your view on “Experimental GLP-1 drug demonstrates pain relief in people with osteoarthritis during trials”?
This is self-selected reader participation, not representative scientific polling.

